drugset / Trial / NCT01522326

Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness

NCT01522326

Completed 300 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to determine the efficacy of metoclopramide in relieving the symptoms of Acute Mountain Sickness (AMS). It is our hypothesis that the combined antiemetic and analgesic effects of metoclopramide (which has been study-proven to be effective in relieving symptoms of migraine headache) will prove to be more efficacious in relieving symptoms of acute mountain sickness than the standard, previously-studied analgesic medication, ibuprofen.

Timeline

Start
2012-03-01
Primary completion
2017-03-01
Completion
2017-03-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg Oral
Subject Metoclopramide Small molecule 10 mg Oral